Bioethics
DTC Genetic Risk Reports Back on Market
By Kayte Spector-Bagdady, JD, MBE & Michele Gornick, PhD, MA On Thursday, April 6th, the FDA announced that it will allow the direct-to-consumer (DTC) genetic testing company 23andMe to market “Genetic Health Risk” (GHR) tests for…